Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Estrogen metabolism and breast cancer.

Literature DB >> 24784887

Estrogen metabolism and breast cancer.

Abstract

There is currently accumulating evidence that endogenous estrogens play a critical role in the development of breast cancer. Estrogens and their metabolites have been studied in both pre- and postmenopausal women with more consistent results shown in the latter population, in part because of large hormonal variations during the menstrual cycle and far fewer studies having been performed in premenopausal women. In this review we describe in detail estrogen metabolism and associated genetic variations, and provide a critical review of the current literature regarding the role of estrogens and their metabolites in breast cancer risk.

Entities: CellLine Chemical Disease Gene Mutation Species

Keywords: Breast cancer; Estrogen; Estrogen metabolites; Postmenopausal women; Premenopausal women; Sex hormones

Mesh：

Substances：

Year: 2014 PMID： 24784887 PMCID： PMC4505810 DOI： 10.1016/j.canlet.2014.04.018

Source DB: PubMed Journal: Cancer Lett ISSN： 0304-3835 Impact factor: 8.679

140 in total

1. Relationship of serum dehydroepiandrosterone (DHEA), DHEA sulfate, and 5-androstene-3 beta, 17 beta-diol to risk of breast cancer in postmenopausal women.

Authors: J F Dorgan; F Z Stanczyk; C Longcope; H E Stephenson; L Chang; R Miller; C Franz; R T Falk; L Kahle
Journal: Cancer Epidemiol Biomarkers Prev Date: 1997-03 Impact factor: 4.254

2. Nature of cytochromes P450 involved in the 2-/4-hydroxylations of estradiol in human liver microsomes.

Authors: V Kerlan; Y Dreano; J P Bercovici; P H Beaune; H H Floch; F Berthou
Journal: Biochem Pharmacol Date: 1992-11-03 Impact factor: 5.858

3. Sex hormones and postmenopausal breast cancer: a prospective study in an adult community.

Authors: C F Garland; N J Friedlander; E Barrett-Connor; K T Khaw
Journal: Am J Epidemiol Date: 1992-06-01 Impact factor: 4.897

Review 4. Changing concepts: Menopausal hormone therapy and breast cancer.

Authors: Rowan T Chlebowski; Garnet L Anderson
Journal: J Natl Cancer Inst Date: 2012-03-16 Impact factor: 13.506

5. An association between the allele coding for a low activity variant of catechol-O-methyltransferase and the risk for breast cancer.

Authors: J A Lavigne; K J Helzlsouer; H Y Huang; P T Strickland; D A Bell; O Selmin; M A Watson; S Hoffman; G W Comstock; J D Yager
Journal: Cancer Res Date: 1997-12-15 Impact factor: 12.701

6. Estrogen metabolism and risk of breast cancer in postmenopausal women.

Authors: Barbara J Fuhrman; Catherine Schairer; Mitchell H Gail; Jennifer Boyd-Morin; Xia Xu; Laura Y Sue; Saundra S Buys; Claudine Isaacs; Larry K Keefer; Timothy D Veenstra; Christine D Berg; Robert N Hoover; Regina G Ziegler
Journal: J Natl Cancer Inst Date: 2012-01-09 Impact factor: 13.506

7. Binding of 2-hydroxyestradiol and 4-hydroxyestradiol to estrogen receptors from human breast cancers.

Authors: C H Van Aswegen; R H Purdy; J L Wittliff
Journal: J Steroid Biochem Date: 1989-04 Impact factor: 4.292

8. Cytochrome P450 1B1 gene polymorphisms and postmenopausal breast cancer risk.

Authors: Tove Rylander-Rudqvist; Sara Wedren; Fredrik Granath; Keith Humphreys; Susanne Ahlberg; Elisabete Weiderpass; Mikael Oscarson; Magnus Ingelman-Sundberg; Ingemar Persson
Journal: Carcinogenesis Date: 2003-07-04 Impact factor: 4.944

9. Role of polymorphic human cytochrome P450 enzymes in estrone oxidation.

Authors: Alastair E Cribb; M Joy Knight; Dagny Dryer; Judy Guernsey; Kimberly Hender; Marvin Tesch; Tarek M Saleh
Journal: Cancer Epidemiol Biomarkers Prev Date: 2006-03 Impact factor: 4.254

10. A CYP19 (aromatase) polymorphism is associated with increased premenopausal breast cancer risk.

Authors: Kathryn E Talbott; Marilie D Gammon; Muhammad G Kibriya; Yu Chen; Susan L Teitelbaum; Chang-Min Long; Irina Gurvich; Regina M Santella; Habibul Ahsan
Journal: Breast Cancer Res Treat Date: 2007-11-02 Impact factor: 4.872

83 in total

1. An estrogen-related lifestyle score is associated with risk of postmenopausal breast cancer in the PLCO cohort.

Authors: Mark A Guinter; Alexander C McLain; Anwar T Merchant; Dale P Sandler; Susan E Steck
Journal: Breast Cancer Res Treat Date: 2018-04-12 Impact factor: 4.872

2. Acetylation targets HSD17B4 for degradation via the CMA pathway in response to estrone.

Authors: Ye Zhang; Ying-Ying Xu; Chuan-Bo Yao; Jin-Tao Li; Xiang-Ning Zhao; Hong-Bin Yang; Min Zhang; Miao Yin; Jing Chen; Qun-Ying Lei
Journal: Autophagy Date: 2017-02-22 Impact factor: 16.016

3. Investigation of the association between the fecal microbiota and breast cancer in postmenopausal women: a population-based case-control pilot study.

Authors: James J Goedert; Gieira Jones; Xing Hua; Xia Xu; Guoqin Yu; Roberto Flores; Roni T Falk; Mitchell H Gail; Jianxin Shi; Jacques Ravel; Heather Spencer Feigelson
Journal: J Natl Cancer Inst Date: 2015-06-01 Impact factor: 13.506

4. Green Tea Catechin Extract Supplementation Does Not Influence Circulating Sex Hormones and Insulin-Like Growth Factor Axis Proteins in a Randomized Controlled Trial of Postmenopausal Women at High Risk of Breast Cancer.

Authors: Hamed Samavat; Anna H Wu; Giske Ursin; Carolyn J Torkelson; Renwei Wang; Mimi C Yu; Douglas Yee; Mindy S Kurzer; Jian-Min Yuan
Journal: J Nutr Date: 2019-04-01 Impact factor: 4.798

5. The association between serum sex steroid hormone concentrations and intraprostatic inflammation in men without prostate cancer and irrespective of clinical indication for biopsy in the placebo arm of the Prostate Cancer Prevention Trial.

Authors: Susan Chadid; John R Barber; William G Nelson; Bora Gurel; M Scott Lucia; Ian M Thompson; Phyllis J Goodman; Frank Z Stanczyk; Howard L Parnes; Scott M Lippman; Angelo M De Marzo; Elizabeth A Platz
Journal: Prostate Date: 2020-06-07 Impact factor: 4.104